178 related articles for article (PubMed ID: 21542999)
21. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
22. Proteinuria is a predictor of posttransplant anemia.
Bonofiglio R; Lofaro D; Greco R; Senatore M; Papalia T
Transplant Proc; 2011 May; 43(4):1063-6. PubMed ID: 21620053
[TBL] [Abstract][Full Text] [Related]
23. Factors affecting the long-term renal allograft survival.
Wang W; Li XB; Yin H; Yang XY; Liu H; Ren L; Hu XP; Wang Y; Zhang XD
Chin Med J (Engl); 2011 Apr; 124(8):1181-4. PubMed ID: 21542992
[TBL] [Abstract][Full Text] [Related]
24. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
25. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
Elmagd MM; Bakr MA; Metwally AH; Wahab AM
Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
[TBL] [Abstract][Full Text] [Related]
26. The risk factors of delayed graft function and comparison of clinical outcomes after deceased donor kidney transplantation: single-center study.
Jung GO; Yoon MR; Kim SJ; Sin MJ; Kim EY; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Lee SK
Transplant Proc; 2010 Apr; 42(3):705-9. PubMed ID: 20430152
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
28. [Acute postoperative renal insufficiency in renal transplantation. Incidence and risk factors].
Hestin D; Frimat L; Hubert J; Renoult E; Claudon M; Muller S; Kessler M
J Radiol; 1994 Jan; 75(1):31-4. PubMed ID: 8151536
[TBL] [Abstract][Full Text] [Related]
29. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
31. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
32. Anaemia after renal transplantation.
Vanrenterghem Y
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V54-58. PubMed ID: 15284361
[TBL] [Abstract][Full Text] [Related]
33. Can preemptive kidney transplantation guarantee longer graft survival in living-donor kidney transplantation? Single-center study.
Jung GO; Moon JI; Kim JM; Choi GS; Kwon CH; Cho JW; Kim SJ
Transplant Proc; 2010 Apr; 42(3):766-74. PubMed ID: 20430167
[TBL] [Abstract][Full Text] [Related]
34. Incidence and factors associated with delayed graft function in renal transplantation at Carlos Van Buren Hospital, January 2000 to June 2008.
Sáinz MM; Toro JC; Poblete HB; Perez LF; Nicovani VH; Carrera MG
Transplant Proc; 2009; 41(6):2655-8. PubMed ID: 19715994
[TBL] [Abstract][Full Text] [Related]
35. Pretransplant soluble CD30 level has limited effect on acute rejection, but affects graft function in living donor kidney transplantation.
Kim MS; Kim HJ; Kim SI; Ahn HJ; Ju MK; Kim HJ; Jeon KO; Kim YS
Transplantation; 2006 Dec; 82(12):1602-5. PubMed ID: 17198243
[TBL] [Abstract][Full Text] [Related]
36. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
Bronzatto EJ; da Silva Quadros KR; Santos RL; Alves-Filho G; Mazzali M
Transplant Proc; 2009 Apr; 41(3):849-51. PubMed ID: 19376369
[TBL] [Abstract][Full Text] [Related]
37. Endogenous erythropoietin levels and anemia in long-term renal transplant recipients.
Zadrazil J; Horák P; Horcicka V; Zahálková J; Strébl P; Hrubý M
Kidney Blood Press Res; 2007; 30(2):108-16. PubMed ID: 17374961
[TBL] [Abstract][Full Text] [Related]
38. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
[TBL] [Abstract][Full Text] [Related]
39. Surgical complications and renal function after kidney alone or simultaneous pancreas-kidney transplantation: a matched comparative study.
Gutiérrez P; Marrero D; Hernández D; Vivancos S; Pérez-Tamajón L; Rodríguez de Vera JM; Alarcó A; González-Posada JM
Nephrol Dial Transplant; 2007 May; 22(5):1451-5. PubMed ID: 17327283
[TBL] [Abstract][Full Text] [Related]
40. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
